Smruthi Organics Share Price Today | Stock Price & Smruthi Organics Share Screener
As of October 5, 2026, the live Smruthi Organics share price (BSE: SMRUTHIORG) is ₹156.60, up 1.29% from the previous close, with shares trading between ₹153.40 and ₹160.00 in today's trading session, and a 52-week range of ₹96.50–₹168.80. Check SMRUTHIORG yearly price range for the annual price range and momentum. Use the Smruthi Organics stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Smruthi Organics opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹112 and net income of ₹8, with EBITDA of ₹18, an operating margin of 16.0% and a profit margin of 7.1%.
Smruthi Organics Share Price Chart
Track the current stock price of Smruthi Organics with an interactive chart. Analyse SMRUTHIORG share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Smruthi Organics stock quote in one place.
The quote of ₹156.60 sits between the 52-week low of ₹96.50 and the 52-week high of ₹168.80, and the latest session moved 1.29% from the previous close.
Smruthi Organics Company Profile - Fundamental Screener
Screen Smruthi Organics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SMRUTHIORG shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE172E01011.
Company Details
Classification
Identifiers and Leadership
Smruthi Organics Balance Sheet Screener
Screen SMRUTHIORG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹104, down from ₹112 in 2025.
Latest statistics put total assets at ₹104 and shareholder funds at ₹74, with a leverage ratio of 0.17.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 104 | 112 | 118 | 106 | 88 | 92 | 88 | 101 | 85 | 85 |
| Current Assets | 53 | 63 | 75 | 65 | 53 | 59 | 53 | 65 | 51 | 44 |
| Fixed Assets | 47 | 45 | 40 | 37 | 33 | 31 | 32 | 30 | 30 | 30 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 4 | 9 | 7 | 2 | 5 | 7 | 7 | 7 | 9 | 11 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 74 | 72 | 70 | 68 | 67 | 61 | 43 | 36 | 29 | 32 |
| Share Capital | 11 | 11 | 11 | 11 | 11 | 11 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 62 | 60 | 58 | 57 | 56 | 49 | 39 | 33 | 25 | 29 |
Smruthi Organics Income Statement Screener - Profit & Revenue Analysis
Screen Smruthi Organics income statement and profit fundamentals. Analyze SMRUTHIORG quarterly results. Smruthi Organics reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹112 and net profit was ₹8, equal to earnings per unit of ₹6.50, at an operating margin of 16%.
In that period expenses were ₹94, interest cost ₹2 and tax ₹3. The next period listed, 2026-March, shows revenue of ₹102 and net profit of ₹3.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||
| Revenue | 112 | 102 | 126 | 128 | 141 | 134 | 127 | 136 | 138 | 98 | 80 | 73 | 75 |
| Expenses | 94 | 89 | 114 | 116 | 131 | 115 | 98 | 116 | 121 | 94 | 69 | 62 | 70 |
Operating Costs and Margins | |||||||||||||
| EBITDA | 18 | 13 | 12 | 12 | 10 | 19 | 29 | 20 | 18 | 4 | 11 | 11 | 5 |
| Operating Profit % | 16.00% | 13.00% | 10.00% | 9.00% | 7.00% | 14.00% | 23.00% | 12.00% | 12.00% | 3.00% | 13.00% | 15.00% | 6.00% |
| Depreciation | 7 | 6 | 6 | 6 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 |
| Interest | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 3 | 4 | 4 | 4 | 5 | 6 |
Profit and Earnings | |||||||||||||
| Profit Before Tax | 10 | 5 | 5 | 5 | 5 | 14 | 24 | 12 | 10 | -5 | 3 | 2 | -6 |
| Tax | 3 | 1 | 1 | 1 | 0 | 3 | 7 | 4 | 3 | -2 | 1 | 1 | -2 |
| Net Profit | 8 | 3 | 4 | 4 | 4 | 10 | 17 | 8 | 7 | -3 | 2 | 1 | -4 |
| EPS | 6.50 | 2.99 | 3.11 | 3.14 | 3.87 | 9.07 | 14.95 | 22.14 | 17.98 | -8.42 | 4.15 | 1.90 | -10.00 |
Smruthi Organics Cash Flow Screener - Liquidity Fundamentals
Screen SMRUTHIORG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹22, and net cash flow was an inflow of ₹1.
Over the same period, investing activities used ₹9 and financing activities used ₹12.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 22 | 10 | 4 | 12 | 2 | 23 | 21 | 12 | 5 | 9 |
| Investing Activities | -9 | -11 | -7 | -10 | 7 | -3 | -5 | -5 | -3 | -1 |
Financing and Net Cash | ||||||||||
| Financing Activities | -12 | 1 | 3 | -2 | -12 | -7 | -18 | -5 | -2 | -9 |
| Net Cash Flow | 1 | 0 | 0 | 0 | -3 | 13 | -1 | 2 | 0 | 0 |
Smruthi Organics Shareholding Pattern Screener
See Smruthi Organics shareholding pattern with promoter, FII, and DII holdings. Check Smruthi Organics promoter holding and ownership changes for SMRUTHIORG on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Jun, promoters held 64.73%, foreign institutions 0.00%, domestic institutions 0.00% and the public 28.65%, spread across 5,959 shareholders.
The shareholder count was 5,959 in 2026-Jun, compared with 6,035 in 2026-Mar.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 64.73% | 64.73% | 64.73% | 64.73% | 64.73% | 64.73% | 63.87% | 63.87% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 28.65% | 28.71% | 28.83% | 28.86% | 28.81% | 28.83% | 29.54% | 29.57% |
| Other Holding | 6.62% | 6.57% | 6.44% | 6.41% | 6.47% | 6.44% | 6.59% | 6.56% |
| Shareholder Count | 5,959 | 6,035 | 6,187 | 6,356 | 6,047 | 5,905 | 5,959 | 5,972 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Smruthi Organics. Smruthi Organics dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹1.50 per unit for 2026-March, a yield of 0.98%, compared with ₹1.50 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹1.50, ₹1.50 and ₹1.50 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹1.50 | 0.98% |
| 2025-March | ₹1.50 | 1.55% |
| 2024-March | ₹1.50 | 1.36% |
| 2023-March | ₹2.00 | 1.37% |
| 2022-March | ₹3.00 | 2.33% |
| 2021-March | ₹3.00 | 1.34% |
| 2020-March | ₹3.00 | 1.35% |
| 2019-March | ₹2.00 | 8.34% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Smruthi Organics Stock Index Membership - Nifty & Sensex
See which indices include Smruthi Organics stock. Check SMRUTHIORG index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Smruthi Organics Market Events Screener - Corporate Actions
Get Smruthi Organics corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Smruthi Organics stock events that may affect SMRUTHIORG share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 10, 2026, with a record date of August 10, 2026.
It is followed by Annual General Meeting dated August 10, 2026 and Dividend dated July 31, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-10 | 2026-08-10 | Quarterly Result Announcement | NA | -0.60% |
| 2026-08-10 | 2026-08-10 | Annual General Meeting | NA | 2.24% |
| 2026-07-31 | 2026-07-31 | Dividend | ₹ 1.50 /share | 1.85% |
| 2026-05-13 | 2026-05-13 | Quarterly Result Announcement | NA | -1.94% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 0.77% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -1.90% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -3.05% |
| 2025-06-20 | 2025-06-20 | Annual General Meeting | NA | 5.97% |
| 2025-06-13 | 2025-06-13 | Dividend | ₹ 1.50 /share | 12.21% |
| 2025-05-05 | 2025-05-05 | Quarterly Result Announcement | NA | -3.50% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | -3.50% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -11.92% |
| 2024-09-14 | 2024-09-14 | Annual General Meeting | NA | -9.38% |
| 2024-09-06 | 2024-09-06 | Dividend | ₹ 1.50 /share | -4.62% |
| 2023-07-28 | 2023-07-28 | Dividend | ₹ 2.00 /share | -20.54% |
Smruthi Organics Competitors Screener - Peer Stocks Comparison
Screen SMRUTHIORG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 447,476 | 36.44 | 61,674 | 12.69% | 11,565 | 40.74 |
| Divis Laboratories | 250,363 | 86.51 | 11,067 | 13.95% | 2,568 | 63.87 |
| Torrent Pharmaceuticals | 186,152 | 85.91 | 13,886 | 20.34% | 2,138 | 46.50 |
| Zydus Life Science | 120,798 | 26.32 | 27,658 | 17.64% | 5,026 | 66.57 |
| Cipla | 111,426 | 33.44 | 29,045 | 2.24% | 3,870 | 45.42 |
| Laurus Labs | 106,838 | 99.70 | 6,868 | 22.01% | 890 | 64.04 |
| Mankind Pharma | 105,107 | 48.73 | 14,636 | 14.85% | 1,938 | 55.24 |
| Dr Reddys Laboratories | 104,492 | 32.05 | 35,059 | 3.90% | 4,158 | 63.11 |
| Aurobindo Pharma | 97,682 | 26.36 | 34,145 | 5.56% | 3,503 | 54.66 |
| Lupin | 93,829 | 16.99 | 29,039 | 26.75% | 5,356 | 35.30 |
Smruthi Organics Company Announcements - News & Reports Screener
Screen SMRUTHIORG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated August 11, 2026 and August 10, 2026.
| Date | Update | Actions |
|---|---|---|
| Closure of Trading Window | - | |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-10 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-10 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-10 | Board Meeting Outcome for Un Audited Quarterly Results Of The Company For The First Quarter Ended 30Th June 2026 | - |
| 2026-08-10 | Un Audited Financial Results Of The Company For The Quarter Ended 30Th June 2026 | - |
| 2026-07-30 | Board Meeting Intimation for Unaudited Financial Results Of The Company For The First Quarter Ended 30Th June 2026. | - |
| 2026-07-21 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-17 | Notice Of Annual General Meeting | - |
| 2026-07-17 | Reg. 34 (1) Annual Report. | - |
| 2026-07-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-29 | Closure of Trading Window | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-14 | Intimation Of Record Date For Payment Of Dividend | - |
| 2026-05-14 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-13 | Intimation Of Date Of Annual General Meeting Of The Company | - |
| 2026-05-13 | Record Date For Dividend | - |
| 2026-05-13 | Book Closure For The Purpose Of The 37Th Annual General Meeting And Payment Of Dividend | - |
| 2026-05-13 | Corporate Action-Board approves Dividend | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹156.60, within a 52-week range of ₹96.50 to ₹168.80. The P/E ratio is 23.58 and the P/B ratio is 2.37, with earnings per unit of ₹2.99. Market capitalisation stands at ₹177.96 Cr and the dividend yield is 0.99%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.